LINC01471

Across TCGA pan-cancer cohorts, LINC01471 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated LINC01471 data layer.

The strongest signal is observed in lymphoid neoplasm diffuse large b-cell lymphoma (DLBC), where higher LINC01471 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01471 expression acts as an unfavorable survival marker, although some lineages such as PAAD and LGG show a favorable association.

DLBC, UCEC, and ACC are the cancer types where LINC01471 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	DFS	Tertile	All	0.359	0.812	.006	88	view →
UCEC	OS	Tertile	All	0.774	0.892	<.001	72	view →
ACC	DFS	Quartile	All	0.203	0.770	.001	40	view →
KICH	OS	Tertile	All	0.155	0.926	<.001	39	view →
LUSC	OS	Tertile	II,III,IV	0.466	0.838	<.001	39	view →
SKCM	OS	Tertile	III,IV	0.562	0.819	<.001	36	view →
KIRP	DFS	Tertile	II,III,IV	0.122	0.626	.032	18	view →
STAD	DFS	Tertile	IV	0.095	0.458	<.001	9	view →
PAAD	DFS	Tertile	All	0.402	0.242	.032	9	view →
PCPG	OS	Tertile	All	0.944	1.000	.045	9	view →
THYM	DFS	Tertile	All	0.664	0.902	.034	9	view →
KIRC	DFS	Quartile	IV	0.225	0.514	.039	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

LINC01471–DLBC (DFS)

Open the DLBC breakdown →